COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING is an esteemed journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving fields of combinatorial chemistry and high-throughput screening. With ISSN 1386-2073 and E-ISSN 1875-5402, this journal provides a critical platform for researchers, professionals, and students engaged in the development and application of novel methodologies aimed at drug discovery and organic chemistry. Since its inception in 1998, the journal has consistently contributed valuable insights, achieving a respectable 2023 Category Quartile Ranking of Q3 across relevant categories including Computer Science Applications, Drug Discovery, and Organic Chemistry. Although it does not currently provide open access options, its rigorous peer-review process and commitment to scientific excellence enhance its reputation in the academic community. Researchers can leverage this journal's findings to stay at the forefront of advancements in their fields, making it an essential resource for anyone dedicated to innovation in chemistry and related disciplines.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.

Pharmaceutical Chemistry Journal is a pivotal publication in the field of pharmaceutical sciences, renowned for its in-depth articles and research findings. Published by Springer in the United States, this journal provides a crucial platform for researchers, students, and professionals dedicated to advancing drug discovery and pharmacology. With an ISSN of 0091-150X and an E-ISSN of 1573-9031, this journal has consistently aimed to promote scholarly communication and innovation within its scope since its inception in 1967. Despite its current Category Quartiles ranking of Q4 in both Drug Discovery and Pharmacology, the journal remains a valuable resource for disseminating new ideas and findings that contribute to the scientific community. Researchers benefit from the journal's commitment to high-quality peer-reviewed content, even in an environment where open access options are currently not available. As the field evolves, the Pharmaceutical Chemistry Journal continues to play an important role in shaping future advancements in drug development and safety.

Chemija is a prominent journal in the field of chemistry, published by LIETUVOS MOKSLU AKAD LEIDYKLA in Lithuania. With a focus on diverse topics within the realm of chemistry, this journal aims to disseminate original research articles, reviews, and discussions that advance the understanding and application of chemical science. Although it currently holds a Q4 ranking in the miscellaneous category of chemistry, Chemija is committed to elevating its impact through the publication of high-quality research, making significant contributions to the discipline. The journal operates under a non-open access model, ensuring that articles undergo rigorous peer review to uphold academic standards. Researchers, professionals, and students are encouraged to explore the wealth of knowledge within its pages as it endeavors to bridge gaps across various subfields of chemistry from 2008 to 2024. With a dedicated readership and a growing database of insightful publications, Chemija serves as an essential resource in the ever-evolving landscape of chemical research.

CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.

Research Journal of Pharmacognosy, published by the Iranian Society of Pharmacognosy, is a pioneering forum for the dissemination of research in the field of pharmacognosy and its related disciplines. Founded in 2014 as an Open Access journal, it aims to provide swift and free access to high-quality research articles, fostering collaboration and innovation among researchers, professionals, and students. Operating from Tehran, Iran, this journal addresses a wide range of topics including complementary and alternative medicine, drug discovery, and organic chemistry, making it an invaluable resource for those researching the extraction, characterization, and application of naturally derived compounds. The journal holds a Category Quartile ranking of Q3 in Complementary and Alternative Medicine and Q4 in both Drug Discovery and Organic Chemistry for the year 2023, which underscores its growing influence within the scientific community. By serving as a platform for current advances and thought leadership in pharmacognosy, the Research Journal of Pharmacognosy plays a crucial role in bridging the gap between traditional practices and modern pharmacological applications.

BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.

MOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.